RNRMarketResearch.com

Global Immunoassay Market Forecast to 2018 by Applications

Press Release   •   Sep 24, 2014 08:27 EDT

RNR presents analysis and discussion about immunoassay market, its forecasts and more is now available in the global research report “Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018”. This report can be ordered at ReportsnReports.com.

Geographically, the Americas commanded the largest market share of the global immunoassay market, followed by Europe. The factors driving the growth of the market in these geographies are the well-established diagnostic infrastructure, aging population, and rising acceptance of personalized medicine. However, on the other hand, the economic downturn and cuts in healthcare budgets are hampering the growth of the market. Countries like China, India, Australia, and Brazil will be major contributors of the growth of the market in the future. This market in China is poised to grow at a CAGR of 15.6% from 2013 to 2018. Increasing investments by leading companies in these immature markets, rising public awareness about personal health, and improving healthcare infrastructure in these regions are driving the growth of the market.

The deviations and the overlap of revenues between the various segments, especially in applications quoted in a number of sources was the major challenge faced while estimating the immunoassay market size. This challenge was overcome by validating the data through a large number of industry experts and key opinion leaders.

From an insight perspective, this immunoassay market research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), value chain, PESTEL analysis, porters five forces analysis, regulations, and reimbursement challenges. The report also offers market shares, sizes, and related growth of various segments of the industry. It also focuses on the emerging and high-growth segments of immunoassay (enzyme and chemiluminescence immunoassay), emerging technologies, high-growth regions, countries, and the initiatives of their respective governments.

The competitive landscape covers the growth strategies adapted by the industry players in the last three years. The company profiles comprise of the basic views on the key players in the immunoassay market and the product portfolios, developments, and strategies adopted to maintain and grow their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovation in the products and technologies, and levels of output in order to remain successful.

Complete report available at http://www.reportsnreports.com/reports/269708-immunoassay-market-technology-enzyme-fluorescent-chemiluminescence-radioimmunoassay-analyzers-reagents-applications-infectious-diseases-cancer-endocrinology-cardiology-end-users-hospitals-laboratory-academics-global-forecast-to-2018.html .

Immunoassay have evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring.

This research report categorizes the global on the basis of technology, application, product (analyzers and reagents), and end user. On the basis of technology, the enzyme immunoassay segment accounted for the largest share of the global market in 2012. Long-term presence in the market, high sensitivity for infectious/viral disease testing, and the huge demand from developing countries due to the lower costs of enzyme immunoassay in comparison to chemiluminescence immunoassay (CLIA) are all factors that are responsible for its growing share in the market. On the basis of product, the reagents market accounted for the largest share of this market in 2012. The accessibility of a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases at early stages are factors that are expected to drive the immunoassay reagents market.

The infectious diseases segment in the immunoassay market is a high-volume, high-growth rate market. Major players such as Roche Diagnostics, Ortho Clinical Diagnostics (J&J), and bioMérieux are continuously launching new product models in order to gain a competitive edge in the infectious diseases segment, primarily because of the high immunoassay penetration rate in this segment.

Inquire for discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=269708 . (Original Price US $4650 for single user)


Table of Contents

1 Introduction

2 Executive Summary

3 Premium Insights

4 Industry Analysis & Market Overview

5 Immunoassay Market, By Technology

6 Immunoassay Market, By Products (Analyzers & Reagents)

7 Immunoassay Market, By Application

8 Global Immunoassay Market, By End-Users

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments) *

List Of Figures

Figure 1 Research Methodology For The Immunoassays Market

Figure 2 Market Size Estimation Methodology For The Immunoassays Market

Figure 3 Forecast Model

Figure 4 Data Triangulation Methodology (360o Evaluation)

Figure 5 Global Immunoassays Market, By Technology, 2013 – 2018 ($Million)

Figure 6 Comparison Of Immunoassay & Other IVD Segments (2013)

Figure 7 Immunoassay Market: Geographic Analysis, 2013 ($Million)

Figure 8 Immunoassay Market: By Applications, 2011 – 2018 (Market Size & Growth Rates)

Figure 9 Immunoassay Market: By Applications, 2013

Figure 10 Immunoassay Market: End-User Analysis, 2013 Vs 2018

Figure 11 Immunoassay Market Key Players: Geographic Reach Vs Product Portfolio (2013)

Figure 12 Immunoassay Market Evolution

Figure 13 Immunoassay Market Segmentation

Figure 14 Immunoassay Market Dynamics

Figure 15 Approval Process Flowchart

Figure 16 Immunoassay Market: Value Chain Analysis For Instruments

Figure 17 Porter’s Five Forces Analysis: Immunoassay Market

Figure 18 Pestel Analysis: Immunoassay Market

Figure 19 Global Immunoassay Market Share Analysis, By Key Players, 2012

Figure 20 Americas: Immunoassay Market Share Analysis, By Key Players, 2012

Figure 21 Europe: Immunoassay Market Share Analysis, By Key Players, 2012

Figure 22 Asia-Pacific: Immunoassay Market Share Analysis, By Key Players, 2012

Figure 23 Global In Vitro Diagnostics Market, By Technique, 2013 ($Million)

Figure 24 Global Immunoassay Market, By Application, 2013 – 2018

Figure 25 Global Immunoassay Market, End-User Positioning

Figure 26 Global Immunoassay Market, By End-Users, 2013 – 2018

Figure 27 Immunoassay Market: Geographic Phases, 2013

Figure 28 Opportunity Matrix: Immunoassay Market, By Country, 2013 – 2018 ($Million)

Figure 29 Key Growth Strategy, 2010 – 2013

Figure 30 Abbott Laboratories, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 31 Abbott Laboratories, Inc.: Business Revenue Mix, 2012

Figure 32 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012

Figure 33 Abbott Laboratories, Inc.: Market Strategy, 2011 – 2013

Figure 34 Alere, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 35 Alere, Inc.: Business Revenue Mix, 2012

Figure 36 Alere, Inc.: Geographic Revenue Mix, 2012

Figure 37 Alere, Inc. Market Strategy, 2011 – 2013

Figure 38 Becton, Dickinson And Company: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 39 Becton, Dickinson And Company: Business Revenue Mix, 2012

Figure 40 Becton, Dickinson And Company: Geographic Revenue Mix, 2012

Figure 41 Becton, Dickinson And Company: Market Strategy, 2011 – 2013

Figure 42 Biomérieux: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 43 Biomérieux: Business Revenue Mix, 2012

Figure 44 Biomérieux: Geographic Revenue Mix, 2012

Figure 45 Biomérieux: Market Strategy, 2011 – 2013

Figure 46 Danaher Corporation: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 47 Danaher Corporation: Business Revenue Mix, 2012

Figure 48 Danaher Corporation: Geographic Revenue Mix, 2012

Figure 49 Danaher Corporation: Market Strategy, 2011 – 2013

Figure 50 Diasorin S.P.A.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 51 Diasorin S.P.A.: Business Revenue Mix, 2012

Figure 52 Diasorin S.P.A.: Geographic Revenue Mix, 2012

Figure 53 Diasorin S.P.A.: Market Strategy, 2011 – 2013

Figure 54 Hologic, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 55 Hologic, Inc.: Business Revenue Mix, 2012

Figure 56 Hologic, Inc.: Geographic Revenue Mix, 2011

Figure 57 Hologic, Inc.: Market Strategy, 2011 – 2013

Figure 58 IDS PLC.: Total Revenue, 2011 – 2013

Figure 59 IDS PLC.: Business Revenue Mix, 2013

Figure 60 IDS PLC.: Geographic Revenue Mix, 2013

Figure 61 Meridian Bioscience, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 62 Meridian Bioscience, Inc.: Business Revenue Mix, 2012

Figure 63 Johnson & Johnson: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 64 Johnson & Johnson: Business Revenue Mix, 2012

Figure 65 Johnson & Johnson: Geographic Revenue Mix, 2012

Figure 66 Johnson & Johnson: Market Strategy, 2011 – 2013

Figure 67 Qiagen N.V.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 68 Qiagen N.V.: Business Revenue Mix, 2012

Figure 69 Qiagen N.V.: Geographic Revenue Mix, 2012

Figure 70 Qiagen N.V.: Market Strategy, 2011 – 2013

Figure 71 Roche Diagnostics: Total Diagnostics Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 72 Roche Diagnostics: Business Revenue Mix (Diagnostics Division), 2012

Figure 73 Roche Diagnostics: Geographic Revenue Mix (Diagnostics Division), 2012

Figure 74 Roche Diagnostics: Market Strategy, 2011 – 2013

Figure 75 Siemens Healthcare: Total Revenue, 2010 – 2012

Figure 76 Siemens Healthcare: Business Revenue Mix, 2012

Figure 77 Siemens Healthcare: Geographic Revenue Mix, 2012

Figure 78 Siemens Healthcare: Market Strategy, 2011 – 2013

Figure 79 Sysmex Corporation: Total Revenue ($Million), 2011 – 2013

Figure 80 Sysmex Corporation: Business Revenue Mix, 2013

Figure 81 Sysmex Corporation: Geographic Revenue Mix, 2013

Figure 82 Sysmex Corporation: Market Strategy, 2011 – 2013

Figure 83 Thermo Fisher Scientific, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012

Figure 84 Thermo Fisher Scientific, Inc.: Business Revenue Mix, 2012

Figure 85 Thermo Fisher Scientific, Inc.: Geographic Revenue Mix, 2012

Figure 86 Thermo Fisher Scientific, Inc.: Market Strategy, 2011 – 2013

Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=269708 . (This is a premium research report priced at US$ 4650 for single user PDF license).


About Us:

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time!